The Big Three K-Beauty ODM Partners Compared: How Indie Founders Choose Between Cosmax, Kolmar, and Intercos in 2026

If you have spent any time asking Korean ODM sourcing questions on your way to a first K-beauty launch (see our complete founder’s guide to starting a K-beauty brand in 2026), three names come back over and over: Cosmax, Kolmar Korea, and Intercos Group. Together they anchor a big share of the K-beauty industry that indie US founders end up buying from, directly or through a broker.

The trouble is that most founders treat the three as interchangeable. They are not. Each one is optimized for a different kind of brand. This guide is a decision map, not a buyer’s directory: which of the Big Three fits the launch you actually have in front of you, and where each will disappoint if you pick for the wrong reason.

Who Are the Big Three K-Beauty ODMs, Really?

The Big Three K-beauty ODMs are Cosmax (KOSPI: 192820), Kolmar Korea (KOSPI: 161890), and Intercos Group (Borsa Italiana: ICOS), each publicly listed and disclosing enough that a founder can research them before a first call. Cosmax and Kolmar Korea are Korean-headquartered and Korean-founded. Intercos is Italian at the parent level but runs a substantial Korean skincare and color operation from Seoul via the former CRB assets it acquired in 2013.

Being publicly listed matters more than founders think. Public disclosures on cosmax.com, kolmar.co.kr, and intercos.com tell you facility footprint, category mix, and R&D investment before you ever sign an NDA. Private ODMs can be better fits for a specific launch, but the Big Three are where new founders get their first read on what a modern K-beauty supply chain looks like.

The Big Three at a Glance

The three ODMs differ most on scale, category depth, geographic footprint, and how they price for indie volumes. The comparison below is drawn from each company’s public disclosures and industry press coverage. Numbers change quarter to quarter; positioning does not.

When Does Cosmax Fit Your Brand?

Cosmax fits founders who need a Korean skincare or color launch at retail scale and want the retailer buyer to recognize the manufacturer name on the QA sheet. Founded in 1992 and now one of the largest ODMs in the world by volume, Cosmax runs at a scale most indie brands will not touch directly on their first PO. The upside is a mature quality system and the “made by Cosmax” halo that lands well in retailer buyer meetings.

The downside is access. Direct Cosmax contracts start above what most first-time founders can commit to in cash. Most indies reach a Cosmax formula through a trading house or an off-the-shelf semi-custom program run by a broker with a slot at the plant. That is not a bad route, but it does mean your “Cosmax launch” is really a broker launch on Cosmax hardware, and your room to iterate on formula changes is thinner.

Cosmax is the right fit if your first PO is at retail scale, your buyer conversation depends on named-manufacturer credibility, and you want an ODM that already runs volume for the big Korean and multinational brands. It is the wrong fit if you are launching one hero SKU under 3,000 units and need daily hand-holding on formula tweaks.

Kolmar Korea's R&D Advantage for Skincare-Heavy Brands

Kolmar Korea is the R&D-first pick when the claim on the front of your bottle depends on formulation science, not story. Spun out of a 1990 joint venture with Kolmar USA, the Korean operation has invested heavily in dermocosmetic labs, actives delivery systems, and clinical support for skincare claims. If your brand promise is a low-dose retinal that does not sting, or a barrier serum with measurable TEWL improvement, Kolmar Korea is a natural home.

The tradeoff is that this R&D depth changes the shape of a project. A serum program at an actives-heavy Korean ODM like Kolmar Korea typically involves more stability rounds, more clinical support, and a longer pre-production timeline than an off-the-shelf semi-custom program at a mid-tier ODM. Founders who need those receipts see it as worth the time. Founders whose story is more about heritage or scent lose the value.

Pick Kolmar Korea when your product story cannot survive without lab receipts. Skip it when your brand narrative is more about ritual, sensorial, or story than mechanism.

Why Would You Pick Intercos Korea Over Cosmax or Kolmar?

You would pick Intercos Korea when color cosmetics anchor your line, when the “Italian-Korean” hybrid narrative is a selling point, or when you want a global ODM that can serve you the same formula out of Milan, Seoul, or New Jersey if you scale into new regions. Intercos Group has been listed on Borsa Italiana in Milan since 2021 and traces its history to 1972 in Italy under founder Dario Ferrari. The Korean operation came in via the 2013 acquisition of CRB, a Seoul-based skincare and color ODM.

For a color-first indie brand, Intercos Korea is often the most natural home among the Big Three. The company runs one of the most extensive lipstick, foundation, and complexion pipelines in the industry, and the Milan pedigree helps prestige positioning at Sephora or Bluemercury reads more “global luxury” than pure K-beauty. Skincare programs exist, but you will often see them positioned as premium and slower to iterate than Kolmar-style R&D projects.

Skip Intercos if your launch is a single skincare hero, if your price point cannot support prestige margins, or if you are optimizing for pure lab-driven claims over positioning. Reach for it when you are building a color range or a premium multi-SKU line where the Italian-Korean hybrid label is doing real narrative work.

The Decision Framework: How Indie Founders Choose

The decision framework is five questions long. Answer them honestly before you request quotes, because the answers change which of the Big Three (or which non-Big-Three ODM) belongs on your shortlist.

1. What is your first PO volume? Under 5,000 units per SKU, direct contracts with any of the three are unlikely; you belong on a trading house or off-the-shelf program. Above 20,000 units per SKU, direct becomes realistic.
2. Does your claim need lab receipts? If a retailer will ask for clinical or stability data to support a hero claim, weight the shortlist toward Kolmar Korea or another R&D-heavy ODM.
3. What category is the hero? Color-first lines lean Intercos Korea. Actives-driven skincare leans Kolmar. Broad skincare or color at retail volume can use Cosmax scale.
4. Who is the retailer buyer? Prestige buyers respond to Intercos positioning. Mass buyers respond to Cosmax scale credibility. Derm-adjacent buyers respond to Kolmar receipts.
5. How much iteration do you need? First-time founders usually underestimate the number of formula rounds. If you need three or more rounds and rapid turn, a smaller ODM outside the Big Three will often serve you better than any of them at this stage.

If four of the five answers point at a smaller ODM, take that seriously. The Big Three are famous because they scaled the industry, not because they are the right fit for every launch. A well-run 200-person Korean ODM will often do a better job on a 3,000-unit indie SKU than a 5,000-person plant that treats you as a small line.

Frequently Asked Questions

Can an indie brand under 1,000 units per SKU actually manufacture with Cosmax, Kolmar, or Intercos?
Directly, almost never. All three quote against internal cost floors that assume larger production runs. Indies at that scale reach these ODMs through trading houses, off-the-shelf semi-custom programs, or shared production slots. A better first question is whether a smaller Korean ODM would serve your launch better than a Big Three slot mediated by a broker. Our MOQ-under-1,000 guide covers that layer of the market.

Is Intercos Korea considered a Korean ODM or an Italian one?
Both, structurally. Intercos Group is Italian and listed in Milan, but the Seoul operation runs Korean R&D, sources Korean actives, and produces domestically. On a label sold to a US retailer, "Made in Korea" is still accurate for goods produced there. Founders who want a purely Korean-founded pedigree may prefer Cosmax or Kolmar; founders who want a hybrid narrative choose Intercos deliberately.

Does the choice of Big Three ODM affect FDA or MOCRA compliance?
Compliance obligations sit with the responsible person named on the US label, not the ODM. All three run to Korean MFDS-compliant standards and can support MOCRA facility registration documentation when they are the manufacturer of record. What differs is turnaround time and how deep their US regulatory team goes for a small brand. Our FDA Korean skincare import guide walks through the founder-side steps.

How does the Big Three shortlist compare with the seven-ODM list I have seen?
The Big Three are the largest, most publicly-visible ODMs. A seven-name list widens to specialist and mid-scale ODMs that fit indie volumes better on many launches. If you have not read it, our seven-ODM overview is the counterweight to this piece: use both together.

Should I get quotes from all three before deciding?
Not blindly. A quote from each of the Big Three costs weeks and burns NDA slots. Do the five-question decision framework first, cut to one or two candidates, then request quotes with a real brief that lets the shortlisted ODMs price accurately. Sending the same brief to five ODMs signals inexperience and slows every response.

By Liz Song, K-beauty sourcing consultant | 7+ years bridging Korean ODMs and US indie brands. Written from Manhattan, NYC. Reviewed for accuracy by ALTA MEET’s formulation consulting team.